Related Experiment Video
Updated: Feb 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Cardiomyopathy: An Overview
Jay Brieler1, Matthew A Breeden1, Jane Tucker1
1Saint Louis University, St. Louis, MO, USA.
Insights
Cardiomyopathy classification has advanced, with primary and secondary types leading to various heart conditions like hypertrophic and dilated cardiomyopathy. Early diagnosis and treatment are crucial for managing heart failure and preventing sudden cardiac death.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Cardiomyopathy definitions and classifications have recently evolved significantly.
- Cardiomyopathies are broadly categorized into primary (genetic, mixed, acquired) and secondary types.
- These conditions manifest in diverse phenotypes, including dilated, hypertrophic, and restrictive patterns.
Purpose of the Study:
- To provide an updated overview of cardiomyopathy classification, phenotypes, and clinical presentations.
- To highlight the role of family physicians in diagnosing and managing various cardiomyopathies.
- To discuss current diagnostic modalities and emerging genetic testing approaches.
Main Methods:
- Review of recent advancements in cardiomyopathy definition and classification.
- Analysis of clinical presentations and diagnostic criteria for different cardiomyopathy types.
- Discussion of therapeutic strategies, including heart failure management, device implantation, and transplantation.
Main Results:
- Hypertrophic cardiomyopathy is the most common primary type, associated with symptoms like dyspnea and risk of sudden cardiac death.
- Dilated cardiomyopathy, often genetic or acquired, typically presents with heart failure symptoms.
- Restrictive cardiomyopathy is less common, often linked to systemic diseases; acquired variants like peripartum cardiomyopathy are also noted.
Conclusions:
- Family physicians must recognize diverse cardiomyopathy presentations, including rare and acquired forms.
- Diagnosis relies on clinical evaluation, electrocardiography, and echocardiography.
- Management involves staged heart failure therapy, activity modification, device consideration, and potential heart transplantation, with genetic testing as an emerging tool.
Abstract:
The definition and classification of cardiomyopathy have evolved considerably in recent years. Cardiomyopathy can be separated into primary (genetic, mixed, or acquired) and secondary categories, which result in varied phenotypes including dilated, hypertrophic, and restrictive patterns. Hypertrophic cardiomyopathy is the most common primary cardiomyopathy and can cause exertional dyspnea, presyncope, atypical chest pain, heart failure, and sudden cardiac death. Dilated cardiomyopathy can be genetic or acquired and typically presents with classic symptoms of heart failure with reduced ejection fraction. Restrictive cardiomyopathy is much less common and often associated with systemic disease. Family physicians should be alert for acquired variants of cardiomyopathy, including peripartum and stress-induced cardiomyopathy, as well as rare variants, such as arrhythmogenic right ventricular dysplasia and left ventricular noncompaction. In addition to history and physical examination, diagnosis of cardiomyopathy includes electrocardiography and echocardiography testing. Treatment may include appropriately staged therapy for heart failure, appropriate activity restriction, evaluation for implantable cardioverter-defibrillator placement, and consideration of heart transplantation in refractory cases. Genetic testing of families is an emerging modality with some potential to augment traditional screening performed by family physicians.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

